NIH Sponsored Clinical Trial for Chelation Trial Picks AIM as a Testing Site

If you, or anyone you know, is over 50 years of age, does not smoke, and have suffered a heart attack more than 6 weeks ago, you may be eligible to participate in a groundbreaking new study.

TACT, the Trial to Access Chelation Therapy, is a clinical trial sponsored by the National Institutes of Health.  This trial involves doctors nation-wide who will test the effectiveness of an alternative therapy for the treatment of coronary heart disease.

As a patient you will receive 28 months of treatment and be asked to participate in 32 months of follow-up.  Participation is at no charge and you will receive vitamin and mineral supplements.

If you are interested in taking part or would like more information about this trial, please contact Asheville Integrative Medicine at 828-252-5545.